The research was backed by the National Institutes of Health and the Department of Defense with seed funding from Mount Sinai. “Routine blood tests represent a very important tool in modern ...

but researchers at Mount Sinai and Memorial Sloan Kettering Cancer Center have developed a promising tool to predict which patients will respond well to the therapy. The tool, an artificial ...